OFIRMEV: payments to doctors
Payments that named OFIRMEV as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 4,280
- Transactions
- 7,829
- Average per transaction
- $155
The per-transaction average — $155 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,280 providers the average total is $283, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mallinckrodt Enterprises LLC | $981,836 | 81.1% |
| Mallinckrodt Hospital Products Inc. | $228,816 | 18.9% |